UNSPSC 51431906: Sapropterin

This classification denotes an antioxidant with the molecular formula C9H15N5O3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier EGX657432I, chemically known as 5,6,7,8-tetrahydrobiopterin but more generally known as sapropterin, which bears U.S. NIH Compound Identifier 1125. European Medicines Agency schedules Sapropterin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10445MIG.

UNSPSC 51431906 Sapropterin is a Commodity code covering specialized pharmaceutical products, specifically sapropterin dihydrochloride and related therapeutic agents. State and local governments procure under this code primarily through their health departments, emergency medical services, and pharmacy benefit programs — acquiring medications for emergency response systems, managed-care pharmacy networks, and state employee health plans. The work involves supplying pharmaceutical manufacturers' products through established wholesaler channels, managing National Drug Codes and product compliance documentation, and ensuring cold-chain logistics and expiration-date management aligned with clinical protocols.

Recent activity shows a mix of issuing bodies and procurement strategies. The City of Tampa's Fire Rescue Department issued IFB 26P00188 in April 2026 for advanced life support medications (response due April 8, 2026) with an estimated contract value of $40,000, requiring nine-month shelf life and firm pricing inclusive of freight to Tampa. The Texas Health and Human Services Commission posted an RFI in March 2026 to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products with awards effective July 1, 2026, requiring vendors to work through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson) and maintain cGMP and Drug Supply Chain Security Act compliance. Activity spans Florida, Texas, and Minnesota cooperatively. The MMCAP procurement emphasizes price competitiveness (75 percent weight) and standardized product data submission, while the Tampa solicitation shelters 5 percent bid discounts for Small Local Business Enterprise participation.